Jiva Ayurveda seeks global recognition to Indian system of medicine

Image
IANS New Delhi
Last Updated : Jul 13 2018 | 6:35 PM IST

Jiva Ayurveda, which runs 80 clinics and hospitals across India, has come out with diagnostic protocols in a bid to get global recognition to the ancient Indian system of medicine. The protocols will be launched on Monday.

"The ayurveda industry has long been wanting a set of protocols to transform the age-old healing tradition into a data and evidence driven system of medicine for wider acceptance in the world," Jiva Ayurveda Director Madhusudan Chauhan told IANS.

Jiva Ayurveda, which created the protocols after analyses of consultation records of two lakh patients its doctors treated over the last decade, has concluded that the practice can be standardized but not treatment as it is personalized.

Unlike allopathy, ayurveda is fundamentally a personalized system of medicine. "Ayurveda is a far more evolved science. Same medicines for same symptoms do not work here. Personalized medicine based on genomics and the 'systems view' of human health is only now coming into fashion in allopathy, while ayurveda is built around these very concepts," he said.

Yet, ayurveda is not accepted as a medical science in many countries as the scientific community asks for data and evidence -- on what basis are the medicines given and how is their effect proven? Chauhan said ayurveda did not have this data and evidence.

Set up in 1992 with the head office in Faridabad, Jiva Ayurveda has more than 350 doctors and 400 healthcare professionals. It has been collating data since 2009 for the purpose of evolving protocols.

"Four years ago, Jiva began a huge data analytics project, reviewing the consultation records of two lakh patients by using artificial intelligence, machine learning and computer modelling. The protocols are now ready," he said.

The protocols and the decision support system built over them will actively help ayurveda practitioners through the entire process of consultation that incorporates patients answers. The system assigns weightage to various factors and arrives at an authoritative diagnosis.

It also suggests diagnostic clues that the doctor may have missed which may lead to a possible different line of treatment.

The protocols, which have been run successfully on 20,000 patients so far, will create a wealth of data that will be validated by domestic and international institutes and universities which will eventually go on to validate ayurveda as a legitimate science of treatment.

"It's a long battle but at least the protocols will open the gates. I believe it will take seven to eight years before ayurveda gets its due recognition. Ayurveda can be India's biggest contribution to the world in this century," said Chauhan.

--IANS

mgu/mag/sed

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 13 2018 | 6:24 PM IST

Next Story